Fisher Scientific (FSH) - Beats, but ...

Looks like I made a good trade for once! I sold Fisher Scientific (FSH) last week and made a nice little profit. Today after the bell, the company released Q2 earnings, which beat the estimates, but they narrowed the range for their full year earnings guidance (in another words they guided down for the year). The stock is down in after hours. The conference call is tomorrow morning so we'll see how the market reacts to their excuse for trimming the guidance. The company also made two small acquisitions today. Like I said before, growth by acquisition is a risky strategy especially when the company is highly leveraged.